About Nanospectra Biosciences
Nanospectra Biosciences is a private company based in Houston, Texas. It has reported $22,273,712 raised in nine offerings on Form D since November 2010. Its chief executive is David Jorden.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 28, 2023 | Mar 15, 2023 | $6,066,104of $10.0M target | 51 | $118K | EquityRule 506(b) | Form D ↗ |
| Sep 3, 2020 | Sep 8, 2020amended Aug 5, 2021 | $8,614,644of $11.2M target | 41 | $210K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 27, 2017 | Feb 10, 2017 | $2,026,497of $4.1M target | 19 | $106K | EquityRule 506(b) | Form D ↗ |
| Dec 4, 2015 | Dec 15, 2015 | $945,995of $1.2M target | 15 | $63,066 | EquityRule 506(b) | Form D ↗ |
| Aug 22, 2014 | Aug 29, 2014 | $800,000fully sold | 15 | $53,333 | EquityRule 506(b) | Form D ↗ |
| Jun 12, 2013 | Jun 17, 2013 | $525,000of $700K target | 3 | $175K | Equity06 | Form D ↗ |
| May 21, 2013 | Jun 4, 2013 | $1,572,500fully sold | 12 | $131K | Equity06 | Form D ↗ |
| May 21, 2013 | Jun 4, 2013 | $849,999fully sold | 14 | $60,714 | Equity06 | Form D ↗ |
| Nov 1, 2010 | Nov 16, 2010 | $872,973of $1.2M target | 11 | $79,361 | Debt, Options06 | Form D ↗ |
| Total, nine offerings | $22,273,712 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nanospectra Biosciences's Form D filed Mar 15, 2023.
BS
Blair Shamel
Director
KS
Kevin Smith
Director
PP
Patrick Pace
Director
BN
Bradley Nyberg
Director
DJ
David Jorden
Chief Executive Officer and director
GG
Glenn Goodrich
Executive officer
Earlier filings also listed Brian Pryor (director, last listed Feb 2017), David Bristol (director, last listed Dec 2015), Jennifer West (director, last listed Aug 2014), J.Donald Payne (president and director, last listed Nov 2010) and David Anderson (director, last listed Nov 2010).